Journals / Türk Geriatri Dergisi / 2008 / Cilt: 11 - Sayı: 4

Current therapeutic methods for hypertension in the elderly

Yaşlılardaki hipertansiyonda güncel tedavi yaklaşımları

Pages
208–216
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Correct application of these rules for geriatric population, will improve morbidity and mortality and positively affect quality of life of elderly patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypertension, as a pathological intercourse, has distinct differences between elderly and younger patients, in terms of pathogenesis, diagnosis and treatment.
📊
Key Findings & Data:Last guidelines published in 2007 by European Society of Cardiology and European Society of Hypertension are valid in Europe and Turkey.
💡
Conclusion & Impact:Correct application of these rules for geriatric population, will improve morbidity and mortality and positively affect quality of life of elderly patients
🔬Design:Review & Systematic Survey
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Hypertension, as a pathological intercourse, has distinct differences between elderly and younger patients, in terms of pathogenesis, diagnosis and treatment. Current concepts about the diagnosis and treatment of hypertension caused review of hypertension in the elderly and update the knowledge about this special situation. Last guidelines published in 2007 by European Society of Cardiology and European Society of Hypertension are valid in Europe and Turkey. Hypertension, as a serious cardiovascular risk factor, should be evaluated by other risk factors and ‘total cardiovascular risk' should be calculated. Treatment of hypertension depends on this parameter. This treatment is case-specific and there are major therapeutic differences between patients, mainly caused by differences of total cardiovascular risk. Correct application of these rules for geriatric population, will improve morbidity and mortality and positively affect quality of life of elderly patients

Özet

Yaşlılardaki hipertansiyon gerek patogenezi, gerekse de tanı ve tedavisindeki farklılıklar nedeniyle populasyonun diğer kesimlerindeki hipertansiyondan farklılıklar gösteren özel bir patolojik süreçtir. Son yıllarda, hipertansiyonun tanı ve tedavisindeki güncel gelişmeler, yaşlılardaki hipertansiyonun yeniden gözden geçirilmesini ve bu konudaki bilgimizin güncellenmesini zorunlu kılmıştır. Avrupa Kardiyoloji ve Hipertansiyon cemiyetlerince 2007'de yayınlanan ve ülkemizde de geçerli kabul edilen son hipertansiyon kılavuzlarına göre, ciddi bir kardiyovasküler risk faktörü olan hipertansiyon, diğer risk faktörleriyle birlikte değerlendirilip, hastanın ‘total kardiyovasküler riski' hesaplanmalıdır. Hipertansiyon tedavisi bu parametreye bağlıdır. Bu tedavi yaşlıya özgü olup, kişiler arasında, esas olarak total kardiyovasküler risklerindeki farklılıklardan kaynaklanan önemli tedavi farklılıkları olabilmektedir. Geriyatrik populasyonda bu bilgilerin doğru biçimde uygulanması, morbidite, mortalite ve yaşam kalitesini olumlu yönde etkileyecektir.

🔖

Cite This Article

ULUÇAM, M. Z., MÜDERRİSOĞLU, H. (2022). Current therapeutic methods for hypertension in the elderly. Türk Geriatri Dergisi, Cilt: 11 - Sayı: 4, 208–216. https://ajindex.com/articles/624199

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: Eur Heart J 2007;28(12):1462-536
  2. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: metaanalysis of outcome trials. Lancet 2000;355(9207):865-72
  3. Izzo, JL. Aging, arterial stiffness, and systolic hypertension. In: Hypertension in the elderly, Prisant M, 2005; Humana Press, NJ, 23-34
  4. Hajjar IM, Grim CE, George V, Kotchen TA. Impact of diet on blood pressure and age-related changes in blood pressure in the US population: analysis of NHANES III. Arch Intern Med 2001;161 (4):589-93
  5. Chobanian AV. Isolated systolic hypertension in the elderly. N Engl J Med 2007;357(8):789-96
  6. Adamopoulos PN, Chrysanthakopoulis SG, Frohlich ED. Systolic hypertension: nonhomogeneous diseases. Am J Cardiol 1975;36(5):697-701
  7. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52
  8. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153(2):154-83
  9. Sowers JR. Hypertension in the elderly. Am J Med 1987 26;82:1-8
  10. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7):479-86
  11. Amery A, Birkenhäger W, Bogaert M, et al. Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE). Clin Exp Hypertens A 1982;4(7):1151-76
  12. Hypertension Detection and Follow-up Program Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Followup Program. JAMA 1988;259(14):2113-22
  13. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J (Clin Res Ed) 1985;291(6488):97-104
  14. Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study. J Hypertens 1992;(12): 1525-30
  15. Thijs L, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A. A meta-analysis of outcome trials in elderly hyp